Dodge & Cox
- SEC CIK
- 0000200217
- Latest filing
- Aug 13, 2026
SNY holding history
Sanofi in every 13F filed by Dodge & Cox, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SNY overviewAll 13F holders of SNYFull Q2 2026 holdings
- Shares (Q2 2026)
- 28,088,274
- Value
- $1.20B
- % of portfolio
- 0.6%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 28,088,274 | $1.20B | 0.6% | −1,416,358−4.8% | Reduced | Holders |
| Q1 2026 | 29,504,632 | $1.42B | 0.8% | −26,987,967−47.8% | Reduced | Holders |
| Q4 2025 | 56,492,599 | $2.74B | 1.5% | −12,439,148−18.0% | Reduced | Holders |
| Q3 2025 | 68,931,747 | $3.25B | 1.8% | −2,786,568−3.9% | Reduced | Holders |
| Q2 2025 | 71,718,315 | $3.46B | 1.9% | −1,474,742−2.0% | Reduced | Holders |
| Q1 2025 | 73,193,057 | $4.06B | 2.3% | −2,027,531−2.7% | Reduced | Holders |
| Q4 2024 | 75,220,588 | $3.63B | 2.1% | −1,076,595−1.4% | Reduced | Holders |
| Q3 2024 | 76,297,183 | $4.40B | 2.5% | −812,450−1.1% | Reduced | Holders |
| Q2 2024 | 77,109,633 | $3.74B | 2.2% | −1,015,976−1.3% | Reduced | Holders |
| Q1 2024 | 78,125,609 | $3.80B | 2.2% | −124,584−0.2% | Reduced | Holders |
| Q4 2023 | 78,250,193 | $3.89B | 2.5% | −258,279−0.3% | Reduced | Holders |
| Q3 2023 | 78,508,472 | $4.21B | 2.8% | −1,991,902−2.5% | Reduced | Holders |
| Q2 2023 | 80,500,374 | $4.34B | 2.9% | −2,016,952−2.4% | Reduced | Holders |
| Q1 2023 | 82,517,326 | $4.49B | 3.1% | −1,671,748−2.0% | Reduced | Holders |
| Q4 2022 | 84,189,074 | $4.08B | 2.8% | +8,538,408+11.3% | Added | Holders |
| Q3 2022 | 75,650,666 | $2.88B | 2.2% | −1,346,616−1.7% | Reduced | Holders |
| Q2 2022 | 76,997,282 | $3.85B | 2.7% | −15,009,442−16.3% | Reduced | Holders |
| Q1 2022 | 92,006,724 | $4.72B | 2.9% | −1,395,325−1.5% | Reduced | Holders |
| Q4 2021 | 93,402,049 | $4.68B | 2.9% | −718,017−0.8% | Reduced | Holders |
| Q3 2021 | 94,120,066 | $4.54B | 3.0% | +23,839,518+33.9% | Added | Holders |
| Q2 2021 | 70,280,548 | $3.70B | 2.4% | +1,219,164+1.8% | Added | Holders |
| Q1 2021 | 69,061,384 | $3.42B | 2.4% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.